Cite Filings / ENGN / 0001140361-26-020024
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

enGene Therapeutics Inc. · Filed 2026-05-08 · Acc 0001140361-26-020024

Documents 1

  • DEF 14A Proxy Statement , ef20072046_def14a.htm

Around this filing

  • 2026-05-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-08 ARS Annual Report to Security Holders
  • 2026-05-08 DEF 14A Proxy Statement
  • 2026-05-07 8-K Executive or director change · Regulation FD disclosure · Other events
  • 2026-05-05 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-05-09 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ef20072046_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…